Skip to main content
. 2022 Apr 8;12:5925. doi: 10.1038/s41598-022-09864-9

Figure 1.

Figure 1

Kaplan–Meier curves of overall survival (OS) of patients with (A) TP53 mutations, (B) NRAS mutations, (C) ASXL1 mutations, (D) JAK2/3 mutations and (E) KRAS mutations had worse OS than wild type patients.